Skip to main content

Animations

MJFF Publications

3491 - 3500 of 6420 Results
Title
Year
  • Year
  • 2022
  • 2019
  • 2023
  • 2024
  • 2021
  • 2020
  • 2023
  • 2018
  • 2009
  • 2019
  • Summary Details
    OPEN
    Title: Integrating Data Directly into Publications with Augmented Reality and Web-Based Technologies – Schol-AR
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-022-01426-y
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27807
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Machine learning nominates the inositol pathway and novel genes in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad345
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Selective Activation of the Spinal Cord with Epidural Electrical Stimulation
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci14070650
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Patient-centred management of Parkinson's disease – Authors' reply
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-023-02338-1
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid β Peptide Fibrils
    Journal Name: Molecular Imaging
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/1536012118796297
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and death
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2008.12.010
    Citation Count: 225
  • Summary Details
    OPEN
    Title: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.012
    Citation Count: 43
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.